Se-Methylselenocysteine

N/A

Report date: 2023/01/07 18:44:56
NME

Base Information

Drug NameSe-Methylselenocysteine
Drug Alias NameMSeCSe-MSCSeMCys
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A